Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab

BACKGROUND AND OBJECTIVES: To investigate the longitudinal dynamic of lymphocyte subsets during treatment with ocrelizumab (OCR) in patients with multiple sclerosis (PwMS). METHODS: A multicenter retrospective study was conducted in 161 PwMS starting treatment with OCR grouped in naive (naive, n = 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Landi, Doriana, Grimaldi, Alfonso, Bovis, Francesca, Ponzano, Marta, Fantozzi, Roberta, Buttari, Fabio, Signoriello, Elisabetta, Lus, Giacomo, Lucchini, Matteo, Mirabella, Massimiliano, Cellerino, Maria, Inglese, Matilde, Cola, Gaia, Nicoletti, Carolina Gabri, Mataluni, Giorgia, Centonze, Diego, Marfia, Girolama Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
RESEARCH Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005049/
https://www.ncbi.nlm.nih.gov/pubmed/35273036
http://dx.doi.org/10.1212/NXI.0000000000001157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005049/
https://www.ncbi.nlm.nih.gov/pubmed/35273036
http://dx.doi.org/10.1212/NXI.0000000000001157

Ejemplares similares